Back to Results
First PageMeta Content
Bristol-Myers Squibb / Cetuximab / Panitumumab / KRAS / Bevacizumab / Immune system / Oxaliplatin / Colorectal cancer / FOLFOX / Medicine / Chemistry / Pharmacology


7.5 PANITUMUMAB, injection, 100 mg/5 mL and 400 mg/20 mL, Vectibix®, Amgen Australia Pty Ltd. Purpose of Application To request that the current Section 100 (Efficient Funding of Chemotherapy Program) Authority Require
Add to Reading List

Document Date: 2015-04-22 23:39:46


Open Document

File Size: 142,39 KB

Share Result on Facebook
UPDATE